Dr. Leen Kawas has shattered ALL the glass ceilings in her quest to chase the American Dream. As a researcher, inventor and founder of a bioscience company, Leen fueled her passion for change with innovation and tenacity, while raising $400 million to lead her company into a groundbreaking IPO.
Dr. Kawas is the Managing General Partner of Propel Bio Partners. She is the co-founder of Athira and a co-inventor of its lead drug candidate ATH-1017, and also invented several of the innovative drug candidates in Athira’s pipeline. Dr. Kawas served as Athira’s chief executive officer and president, and as a member of its board of directors from January 2014-2021. In this role, she led the technological and financial growth of Athira, raising around $400M and taking the company through its public offering. According to Business Insider and GeekWire, Dr. Kawas was one of only 22 female founders and CEOs to lead their company to an IPO, as of February 2021, and was the first woman to guide a company through an IPO in Washington State in over 20 years (at the time of Athira’s IPO in September 2020).
Join us for this in-depth talk about Dr. Kawas' journey through the IPO process, the need for women at the executive level and why bioscience is so personal for her.
Episode 72: JJ DiGeronimo
Episode 71: Irena Azaraev
Episode 70: Victoria Pelletier
Episode 69: Laura Gisborne
Episode 68: Beth McDaniel
Episode 67: Celina Shands
Episode 66: Limor Bergman Gross
Episode 65: Deb Curtis
Episode 64: Crystal O’Connor
Episode 63: Ann Carden
Episode 62: Janet Livingstone
Episode 61: Tina Lee and Stacey Nowlin
Episode 60: Alyse Maslonik
Episode 59: Sabrina Runbeck
Episode 58: Dr Laura Purdy
Episode 57: Paige Lawrence
Episode 56: Cara Kamenev
Episode 55: Linda Criblez
Episode 54: Bianca D’Alessio
Episode 53: Ashley Ford
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money